Takeda Pharmaceutical
TAK
#332
Rank
$69.55 B
Marketcap
$21.77
Share price
1.68%
Change (1 day)
54.51%
Change (1 year)

P/S ratio for Takeda Pharmaceutical (TAK)

P/S ratio as of November 2026 (TTM): 2.37

According to Takeda Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.49. At the end of 2026 the company had a P/S ratio of 1.93.

P/S ratio history for Takeda Pharmaceutical from 2009 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20261.9310.89%
20251.7423.68%
20241.41-8.28%
20231.53-6.23%
20221.6418.45%
20211.38-26.7%
20201.88-9.68%
20192.0928.45%
20181.62-41.63%
20172.7836.52%
20162.04-21.82%
20152.6127.04%
20142.05-5.84%
20132.1818.6%
20121.84-2.41%
20111.88-19.37%
20102.3411.88%
20092.09

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.59 178.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.00 111.29%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.47 4.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
6.10 157.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.92-18.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
4.93 108.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2.16-8.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
18.8 692.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
3.53 49.07%๐Ÿ‡ฎ๐Ÿ‡ณ India